Replies to post #242099 on Biotech Values

[vinmantoo]

NKTR -24%/AH on_termination_of Bempeg program following phase-3 failures in RCC and bladder cancer:

I have never owned NKTR but its collapse has been astonishing. I just took a look at its stock price over time. NKTR was at $108 about 4 years ago and is now just over $4 a shares. Ouch!

[DewDiligence]

NKTR schedules CC regarding “new strategic plan”:

https://www.prnewswire.com/news-releases/nektar-therapeutics-to-host-webcast-conference-call-for-analysts--investors-to-outline-new-strategic-plan-301530770.html

Should be an ample amount of hot air on this CC.